Abstract
Acute mesenteric ischemia (AMI) accounts for only 1–2 per 1,000 hospital admissions but continues to be a highly complex clinical problem with a relatively high mortality rate. In a population-based autopsy study, the incidence of thromboembolic occlusion of the superior mesenteric artery with intestinal gangrene was 6.0/1,000 deaths, with the diagnosis carrying a mortality of 93 %. The problem was suspected antemortem in only 1/3 of patients. The mortality rate from AMI has declined only very moderately from 80–90 % in the 1970s to 60–70 % in the 1980s. This was largely attributed to a higher index of suspicion among clinicians, advances in radiographic diagnosis, and an aggressive surgical approach with better perioperative care. However, following this, traditional treatment yielded no further improvement in mortality over the previous two decades. In order to further impact the grave outcome of AMI, an endovascular first treatment paradigm has been championed over the last decade. Indeed, endovascular treatment does offer some definite advantages and has been utilized very effectively in the more elective treatment of chronic mesenteric ischemia (CMI). While it is being increasingly used for revascularization in AMI, the main drawback is that it does not allow for immediate assessment of intestinal viability, limiting its applicability to select patients in whom immediate laparotomy is not indicated. In addition, personnel with advanced endovascular skills and an extensive inventory of endovascular devices and equipment may not be readily available in many facilities. It is, therefore, more ideally suited for patients presenting somewhat subacutely and without peritoneal signs.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Stoney RJ, Cunningham CG. Acute mesenteric ischemia. Surgery. 1993;114(3):489–90.
Acosta S, et al. Incidence of acute thrombo-embolic occlusion of the superior mesenteric artery – a population-based study. Eur J Vasc Endovasc Surg. 2004;27(2):145–50.
Kougias P, Lau D, El Sayed HF, Zhou W, Huynh TT, Lin PH. Determinants of mortality and treatment outcome following surgical interventions for acute mesenteric ischemia. J Vasc Surg. 2007;46(3):467–74.
Mamode N, Pickford I, Leiberman P. Failure to improve outcome in acute mesenteric ischaemia: seven-year review. Eur J Surg. 1999;165(3):203–8.
Fioole B, van de Rest HJ, Meijer JR, van Leersum M, van Koeverden S, Moll FL, et al. Percutaneous transluminal angioplasty and stenting as first-choice treatment in patients with chronic mesenteric ischemia. J Vasc Surg. 2010;51(2):386–91.
Arthurs ZM, Titus J, Bannazadeh M, Eagleton MJ, Srivastava S, Sarac TP, et al. A comparison of endovascular revascularization with traditional therapy for the treatment of acute mesenteric ischemia. J Vasc Surg. 2011;53(3):698–704.
Acosta S, Bjorck M. Modern treatment of acute mesenteric ischaemia. Br J Surg. 2014;101(1):e100–8.
Schermerhorn ML, Giles KA, Hamdan AD, Wyers MC, Pomposelli FB. Mesenteric revascularization: management and outcomes in the United States, 1988–2006. J Vasc Surg. 2009;50(2):341–8 e1.
Peck MA, Conrad MA, Kwolek CJ, LaMuraglia GM, Paruchuri V, Cambria RP. Intermediate-term outcomes of endovascular treatment for symptomatic chronic mesenteric ischemia. J Vasc Surg. 2010;51(1):140-7 e1–2.
Oderich GS, Malgor RD, Ricotta 2nd JJ. Open and endovascular revascularization for chronic mesenteric ischemia: tabular review of the literature. Ann Vasc Surg. 2009;23(5):700–12.
Lee RW, Bakken AM, Palchik E, Saad WE, Davies MG. Long-term outcomes of endoluminal therapy for chronic atherosclerotic occlusive mesenteric disease. Ann Vasc Surg. 2008;22(4):541–6.
Atkins MD, Kwolek CJ, LaMuraglia GM, Brewster DC, Chung TK, Cambria RP. Surgical revascularization versus endovascular therapy for chronic mesenteric ischemia: a comparative experience. J Vasc Surg. 2007;45(6):1162–71.
Ryer EJ, et al. Revascularization for acute mesenteric ischemia. J Vasc Surg. 2012;55(6):1682–9.
Park WM, Gloviczki P, Cherry Jr KJ, et al. Contemporary management of acute mesenteric ischemia: factors associated with survival. J Vasc Surg. 2002;35(3):445–52.
Meng X, Liu L, Jiang H. Indications and procedures for second-look surgery in acute mesenteric ischemia. Surg Today. 2010;40(8):700–5.
Bradbury AW, et al. Mesenteric ischaemia: a multidisciplinary approach. Br J Surg. 1995;82(11):1446–59.
Kougias P, et al. Determinants of mortality and treatment outcome following surgical interventions for acute mesenteric ischemia. J Vasc Surg. 2007;46(3):467–74.
Edwards MS, C GS, Craven TE, Olsen AW, Plonk GW, Geary RL, et al. Acute occlusive mesenteric ischemia: surgical management and outcomes. Ann Vasc Surg. 2003;17(1):72–9.
Endean ED, et al. Surgical management of thrombotic acute intestinal ischemia. Ann Surg. 2001;233(6):801–8.
Endean ED, Barnes SL, Kwolek CJ, Minion DJ, Schwarcz TH, Mentzer Jr RM. Surgical management of thrombotic acute intestinal ischemia. Ann Surg. 2001;17(1):801–8.
Block TA, Acosta S, Bjorck M. Endovascular and open surgery for acute occlusion of the superior mesenteric artery. J Vasc Surg. 2010;52(4):959–66.
Acosta S, Sonesson B, Resch T. Endovascular therapeutic approaches for acute superior mesenteric artery occlusion. Cardiovasc Intervent Radiol. 2009;32(5):896–905.
Bjornsson S, et al. Thrombolysis for acute occlusion of the superior mesenteric artery. J Vasc Surg. 2011;54(6):1734–42.
Heiss P, et al. Primary percutaneous aspiration and thrombolysis for the treatment of acute embolic superior mesenteric artery occlusion. Eur Radiol. 2010;20(12):2948–58.
Wyers MC, Powell RJ, Nolan BW, Cronenwett JL. Retrograde mesenteric stenting during laparotomy for acute occlusive mesenteric ischemia. J Vasc Surg. 2007;45(2):269–75.
Millner R, Woo EY, Carpenter JP. Superior mesenteric artery angioplasty and stenting via a retrograde approach in a patient with bowel ischemia – a case report. Vasc Endovasc Surg. 2004;38(1):89–91.
Stout CL, Messerschmidt CA, Leake AE, et al. Retrograde open mesenteric stenting for acute mesenteric ischemia is a viable alternative for emergent revascularization. Vasc Endovasc Surg. 2010;44(5):368–71.
Coelho Macedo RA, Oderich GS, Manju K, Stone D, Woo E, Panneton J, et al. Multicenter experience with retrograde open mesenteric artery stenting via laparotomy for treatment of acute and chronic mesenteric ischemia. J Vasc Surg. 2014;59(2):565–6.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this chapter
Cite this chapter
David, R.A., Kalra, M. (2015). Results of Open and Endovascular Revascularization for Acute Mesenteric Ischemia. In: Oderich, G. (eds) Mesenteric Vascular Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-1847-8_20
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1847-8_20
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-1846-1
Online ISBN: 978-1-4939-1847-8
eBook Packages: MedicineMedicine (R0)